Leuprorelin

Records for this ingredient, by country (identity only).

ATC L02AE02 · 9 markets · 79 records

Leuprorelin 9 markets · 79 records Forms
Filters
Kind

GB 30 records · 9 shown of 9 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

JP 12 records · 4 shown of 4 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

  • 3.75 mg per mL / per unit basis not statedinjectionリュープリン注射用1.88mgリュープリン注射用キット3.75mg、リュープロレリン酢酸塩注射用キット3.75mg「NP」、リュープロレリン酢酸塩注射用キット3.75mg「あすか」
  • 11.25 mg per mL / per unit basis not statedinjectionリュープリンSR注射用キット11.25mgリュープロレリン酢酸塩SR注射用キット11.25mg「NP」、リュープロレリン酢酸塩SR注射用キット11.25mg「あすか」
  • 1.88 mg per mL / per unit basis not statedinjectionリュープリン注射用1.88mgリュープリン注射用キット3.75mg、リュープロレリン酢酸塩注射用キット3.75mg「NP」、リュープロレリン酢酸塩注射用キット3.75mg「あすか」
  • 22.5 mg per mL / per unit basis not statedinjectionリュープリンPRO注射用キット22.5mg

AU 11 records · 6 shown of 6 Source PBS Schedule API v3 (Department of · Data as of 2026-10-01

Only this ingredient

  • 30 mg per mL / per unit basis not statedinjection · extended-releaseEligard 4 monthLucrin Depot 4 Month PDS、Lucrin Depot Paediatric 30 mg PDS
  • 22.5 mg per mL / per unit basis not statedinjection · extended-releaseEligard 3 monthLucrin Depot 3 Month PDS
  • 45 mg per mL / per unit basis not statedinjection · extended-releaseEligard 6 monthLucrin Depot 6-Month
  • 7.5 mg per mL / per unit basis not statedinjection · extended-releaseEligard 1 monthLucrin Depot 7.5mg PDS

Combination products containing this ingredient

  • 22.5 mgtablet · extended-release CombinationBicalutamide 50 mg + Leuprorelin 22.5 mgBi ELIGARD CP
  • 7.5 mgtablet · extended-release CombinationBicalutamide 50 mg + Leuprorelin 7.5 mgBi ELIGARD CP

ES 8 records · 7 shown of 7 Source CIMA (AEMPS) · Data as of live

Only this ingredient

CN 6 records · 4 shown of 4 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 3.75 mg per mL / per unit basis not statedinjection抑那通亮丙瑞林Manufacturer: TakedaPharmaceuticalCompany…、Manufacturer: 上海丽珠制药有限公司
  • 11.25 mg per mL / per unit basis not statedinjectionManufacturer: TakedaPharmaceuticalCompany… ×2
  • 1.88 mg per mL / per unit basis not statedinjection抑那通亮丙瑞林
  • 3.75 mg per mL / per unit basis not statedinjection · extended-releaseManufacturer: 北京博恩特药业有限公司

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

  • 42 mg/syringe per mL / per unit basis not statedinjection · extended-releaseCAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.